Unicycive (UNCY) EVP receives 169,500 RSUs vesting over 3 years

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Gupta Pramod reported acquisition or exercise transactions in this Form 4 filing.

Unicycive Therapeutics EVP Pramod Gupta received a grant of 169,500 restricted stock units (RSUs) payable in common stock. This equity award was granted at no cash cost to him and represents stock-based compensation rather than an open-market share purchase or sale.

According to the footnote, the RSU award vests in three equal parts: one-third on each anniversary of the grant date over three years, as long as Gupta continues his service with the company. Following this grant, he holds 169,500 RSUs directly, aligning his compensation more closely with Unicycive’s future share performance.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gupta Pramod

Role EVP, Pharmaceuticals and BD

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	169,500	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 169,500 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSUs granted: 169,500 units Transaction price per RSU: $0.00 per unit RSUs after transaction: 169,500 units +1 more

4 metrics

RSUs granted 169,500 units Restricted Stock Unit award on May 14, 2026

Transaction price per RSU $0.00 per unit Compensation grant, not open-market purchase

RSUs after transaction 169,500 units Total RSUs directly held following grant

Vesting schedule 1/3 each year over 3 years Annually on grant-date anniversary, subject to continued service

Key Terms

Restricted Stock Unit, RSU Award, vest, continued service

4 terms

Restricted Stock Unit financial

"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

RSU Award financial

"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock"

vest financial

"The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

continued service financial

"for 3 years, subject to the Reporting Person's continued service with the Issuer"

Form 4 Insider Transactions: What Each Field Means →

05/20/2026 - 04:30 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gupta Pramod

(Last)

(First)

(Middle)

C/O UNICYCIVE THERAPEUTICS, INC.

1975 W. EL CAMINO REAL, SUITE 204

(Street)

MOUNTAIN VIEW

CALIFORNIA

94040

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Unicycive Therapeutics, Inc. [ UNCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Pharmaceuticals and BD

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	$0	05/14/2026		A		169,500		⁽¹⁾	⁽¹⁾	Common Stock	169,500	$0	169,500	D

Explanation of Responses:

1. Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years, subject to the Reporting Person's continued service with the Issuer.

	/s/ Pramod Gupta	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Unicycive (UNCY) report for Pramod Gupta?

Unicycive reported that EVP Pramod Gupta received a grant of 169,500 restricted stock units. These RSUs are payable in common stock and represent stock-based compensation, not an open-market share purchase or sale. The award increases his direct equity-linked holdings.

How many RSUs did Unicycive EVP Pramod Gupta receive in this Form 4?

Pramod Gupta received 169,500 restricted stock units in this transaction. Each RSU is payable solely in Unicycive common stock, providing upside if the share price rises. The grant was made at a stated price of $0.00 per unit as part of compensation.

What is the vesting schedule for Pramod Gupta’s 169,500 Unicycive RSUs?

The 169,500 RSUs vest in three equal installments over three years. One-third of the award vests on each anniversary of the grant date, as long as Gupta continues his service with Unicycive, creating a multi-year retention and performance incentive.

Does Pramod Gupta need to pay cash for his Unicycive RSU grant?

No cash payment is required from Pramod Gupta for this RSU grant. The Form 4 lists a transaction price of $0.00 per unit, indicating the award is part of his compensation package rather than a purchased position in the open market.

How many Unicycive equity-linked units does Pramod Gupta hold after this grant?

After this RSU award, Pramod Gupta holds 169,500 restricted stock units directly. These units are payable in Unicycive common stock and will convert into shares as they vest over three years, subject to his continued service with the company.

Is this Unicycive (UNCY) Form 4 a buy or sell signal from the EVP?

The filing shows an equity grant, not a buy or sell trade. Gupta acquired 169,500 RSUs as a compensation award, with no open-market purchase or sale reported. It mainly reflects standard executive incentive alignment rather than active trading sentiment.